"advanced development of vaccine candidates for biodefense and emerging infectious diseases".
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93018C00024
- Awardee
-
Vaxine PTY LTD UEI Z9AUC2SNX5A4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,832,656
Award facts
- Opportunity
-
- HHSNIHNIAIDBAA20171 Solicitation number
- Contract value 32% obligated
-
- $5,832,656.00 Current, with exercised options
- $18,005,775.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 24 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Australia
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$535,698 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $3,532,876 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,835,478 |
About this award
This is a $18,005,775.00 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Vaxine PTY LTD, a for-profit organization based in Australia. The contract is for the advanced development of the H7-Advax pandemic vaccine candidate through Phase 1 clinical trials, including the delivery of preliminary data regarding the adjuvant formulations and the manufactured product. The contract does not have a set-aside designation, and it is scheduled to be completed by August 14, 2023.
Quick answers
Who was awarded contract 75N93018C00024?
75N93018C00024 was awarded to Vaxine PTY LTD by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 20, 2018.
How much is contract 75N93018C00024 worth?
The government has obligated $5,832,656 on 75N93018C00024. Its potential value, with all options, is $18,005,775.
Was contract 75N93018C00024 competed?
The extent of competition for 75N93018C00024 was full and open competition. The government received 24 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award